Cited by 10Coenzyme Q10 studies and effectsHIV-related health complications and treatmentsHIV/AIDS drug development and treatment

Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence

Open access
Chen, Yi-Fan, Hebert, Valeria Y., Stadler, Krisztian, Xue, Stephen Y., Slaybaugh, Kate, Luttrell-Williams, Elliot, Glover, Mitzi C., Krzywanski, David M. +1 more·2019·Cardiovascular Toxicology

Abstract

Human immunodeficiency virus (HIV)-infected patients undergoing antiretroviral therapy are afforded an increased lifespan but also exhibit an elevated incidence of cardiovascular disease. HIV therapy uses a combination drug approach, and nucleoside reverse transcriptase inhibitors (NRTI) are a backbone of this therapy. Endothelial dysfunction is an initiating event in cardiovascular disease etiology, and in our prior studies, NRTIs induced an endothelial dysfunction that was dependent upon mitochondrial oxidative stress. Moreover, short-term NRTI administration induced a mitophagy-associated endothelial toxicity and increased reactive oxygen species (ROS) production that was rescued by coenzyme Q10 (Q10) or overexpression of a mitochondrial antioxidant enzyme. Thus, our objective was to examine mitochondrial toxicity in endothelial cells after chronic NRTI treatment and evaluate Q10 as a potential adjunct therapy for preventing NRTI-induced mitochondrial toxicity. Human aortic endothelial cells (HAEC) were exposed to chronic NRTI treatment, with or without Q10. ROS production, cell proliferation rate, levels of senescence, and mitochondrial bioenergetic function were determined. Chronic NRTI increased ROS production but decreased population doubling. In addition, NRTI increased the accumulation of β-galactosidase, indicative of an accelerated rate of senescence. Moreover, ATP-linked respiration was diminished. Co-treatment with Q10 delayed the onset of NRTI-induced senescence, decreased ROS production and rescued the cells' mitochondrial respiration rate. Thus, our findings may suggest antioxidant enrichment approaches for reducing the cardiovascular side effects of NRTI therapy.

Integrity signals

Registry

Crossref · 10.1007/s12012-019-09520-1

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Coenzyme Q10, SkQ1, mitoquinone and methylene blue are among mitochondria targeted antioxidants exerting a role in counteracting OS-induced senescence, with CoQ10 being the most studied.

    “Coenzyme Q10 (CoQ10), SkQ1 (a.k.a. visomitin), mitoquinone (MitoQ) and methylene blue are among the mitochondria targeted antioxidants exerting a role in counteracting OS-induced senescence, with CoQ10 being the most studied (Table 1 and Table 2) [57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82].”
  • CoQ10 supplementation reverts in vitro the NRTI-induced oxidative damage, senescence, and endothelial toxicity phenotype in human aortic endothelial cells.

    “Recently, Chen et al. demonstrated that this phenotype could be reverted in vitro when human aortic endothelial cells are supplemented with CoQ10 [59]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, Y.-F., Hebert, V. Y., Stadler, K., Xue, S. Y., Slaybaugh, K., Luttrell-Williams, E., Glover, M. C., Krzywanski, D. M., & Dugas, T. R.
Affiliations
  • Louisiana State University Health Sciences Center Shreveport (US)
  • Louisiana State University Health Sciences Center New Orleans (US)
  • Louisiana State University (US)
Corresponding author
Dugas, Tammy R.
Venue
Cardiovascular Toxicology
Published
2019-04-24
Volume
19
Issue
6
Pages
500-509
ISSN
  • 1530-7905 (ISSN-L)
  • 1559-0259
OpenAlex
W2941212302
Cited by
10
References
39
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 2
FWCI
0.50
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • Civil War Book Review (submittedVersion)
Funders
School of Veterinary Medicine, Louisiana State University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
coenzyme Q10, nucleoside reverse transcriptase inhibitors, endothelial cell senescence, mitochondrial toxicity, oxidative stress, reactive oxygen species, endothelial dysfunction, mitochondrial respiration, HIV, antioxidant therapy, beta-galactosidase, ATP-linked respiration, mitophagy
MeSH terms
Antioxidants, Cells, Cultured, Energy Metabolism, Humans, Mitochondria, Ubiquinone, Signal Transduction, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, Reverse Transcriptase Inhibitors, Cytoprotection, Endothelial Cells, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review